The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE "EMAGINE" STUDY)
Public ClinicalTrials.gov record NCT05044507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter study that will be conducted at approximately 20 centers. BQ 2.0 is a wearable medical device that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. In this study, BQ 2.0 is intended to reduce disability in adult patients with subacute ischemic stroke, with a moderate to severe disability which includes an upper extremity motor impairment. BQ 2.0 will be used for 9 weeks in conjunction with physical and occupational therapy (PT/OT) and periodic supervision (either remote or in person) of a trained site study team member. Treatments may be administered in multiple settings (e.g. acute care hospital (ACH) or inpatient rehabilitation facilities (IRF), Skilled Nursing Facility (SNF), home or other outpatient setup). The study will enroll up to 150 adult subjects who will be randomly assigned (1:1 allocation ratio) to either active or sham study intervention using BQ 2.0.
Study identification
- NCT ID
- NCT05044507
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2021
- Primary completion
- Nov 5, 2023
- Completion
- Jan 15, 2024
- Last update posted
- Mar 18, 2024
2021 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rancho Research Institute | Downey | California | 90242 | — |
| Ronald Reagan UCLA Medical Center & California Rehabilitation Institute | Los Angeles | California | 90095 | — |
| MedStar National Rehabililtaion Hospital, | Washington D.C. | District of Columbia | 20010 | — |
| Brooks Rehabilitation Hospital - University Campus | Jacksonville | Florida | 32216 | — |
| The Miami Project to Cure Paralysis | Miami | Florida | 33136 | — |
| Shirley Ryan Abilitylab | Chicago | Illinois | 60611 | — |
| KU Medical Center | Kansas City | Kansas | 66160 | — |
| Spaulding Rehabilitation Hospital | Boston | Massachusetts | 02129 | — |
| JFK Johnson Rehabilitation Institute | Edison | New Jersey | 08820 | — |
| Kessler Institute of Rehabilitation | West Orange | New Jersey | 07052 | — |
| NYP Brooklyn Methodist Hospital Outpatient Rehabilitation | Brooklyn | New York | 11215 | — |
| Atrium Health Carolinas Rehabilitation | Charlotte | North Carolina | 28203 | — |
| Moss Rehabilitation Research Institute | Elkins Park | Pennsylvania | 19027 | — |
| Baylor Scott & White Institute for Rehabilitation | Dallas | Texas | 75246 | — |
| TIRR Memorial Hermann Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05044507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2024 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05044507 live on ClinicalTrials.gov.